Eli Lilly and Company · 1 day ago
Executive Director - Mass Spectrometry-based Biomarker Discovery - Neuroscience
Eli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana, focused on making life better for people around the world. The Executive Director will lead efforts in biomarker discovery and validation for neurodegenerative conditions, overseeing a skilled team and driving strategic development of biomarker assays essential for advancing the neuroscience pipeline.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Lead the development and validation of novel mass spectrometry-based biomarker assays for early- and late-phase clinical trials in neurodegenerative diseases, including Alzheimer’s, Parkinson’s, ALS, and rare brain disorders
Oversee and mentor a team of biomarker researchers at Lilly’s laboratories in Boston, focusing on mass spectrometry-based assay development
Serve as a scientific and technical expert for in-house and outsourced biomarker discovery efforts, guiding experimental study design and analytical strategies
Collaborate cross-functionally with internal stakeholders (medical, operations, statistics, regulatory) and external partners (CROs, academic institutions) to ensure biomarker validation and successful integration into clinical programs
Communicate findings through presentations, publications, and strategic discussions, reinforcing Lilly’s leadership in biomarker innovation
Qualification
Required
PhD in Neuroscience, Biochemistry or a related field
8+ years of industry, academic, or postdoctoral experience in biomarker development
Recognized expertise in mass spectrometry-based assays for brain diseases
Preferred
Proven leadership in managing and mentoring biomarker research teams in academic or industry settings
Deep knowledge of mass spectrometry technology including instrument setup, optimization and maintenance
Deep understanding of mass spectrometry-based assay development, validation, and regulatory requirements for biomarker applications in clinical trials
Strong strategic thinking, problem-solving abilities, and the ability to drive innovation in biomarker discovery
Excellent communication, collaboration, and negotiation skills to influence both internal and external stakeholders
Demonstrated ability to translate scientific insights into impactful clinical applications
Benefits
Company bonus
Company-sponsored 401(k)
Pension
Vacation benefits
Eligibility for medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
Recent News
2026-01-06
2026-01-06
Company data provided by crunchbase